🔎 Trials Near Me

Gara Jalqabaatti › Kansarii Ovarii › Rhode Island

Qorannoo klinikaalii Kansarii Ovarii Rhode Island keessatti

Qorannoo 16 Kansarii Ovarii f Rhode Island keessatti hirmaatuu jiru.

Magaalota Rhode Island keessatti

Takkalaa qorannoo (Ingiliffa)

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

  • Smilow Cancer Hospital Care Center - Westerly, Westerly
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07001748

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • Women and Infants Hospital, Providence
  • Roger Williams Medical Center, Providence
Namoota walitti qabaa jiraSadarkaa 2
Umuriin hundi · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05564377

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

  • Research Site, Providence
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05797168

TLR9 Immunotherapy for Peritoneal Carcinomatosis

  • Rhode Island and the Miriam Hospitals (Brown University Health), Providence
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07658196

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

  • Women & Infants Hospital /ID# 277930, Providence
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Dubartoota · Haaromfame 01-Onk-2026 · NCT07024784

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  • Women & Infants Hospital, Providence
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07213804

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

  • Women & Infants Hospital ( Site 0001), Providence
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Dubartoota · Haaromfame 17-Ful-2026 · NCT07318558

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

  • Women and Infants Hospital, Providence
Namoota walitti qabaa jira
Umuriin 35 hanga 50 · Dubartoota · Haaromfame 07-Hag-2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  • Women and Infants Hospital, Providence
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Hag-2026 · NCT06580314

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  • Women and Infants Hospital of Rhode Island, Providence
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT05579366

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • Lifespan Cancer Institute - Rhode Island Hospital, Providence
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 8 fi ol · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT05503797

Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women

  • Women's and Infant's Hospital, Providence
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 50 hanga 74 · Dubartoota · Haaromfame 06-Cam-2026 · NCT00539162

A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer

  • Site 0191, Providence
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Dubartoota · Haaromfame 07-Elb-2026 · NCT04516447

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Providence
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.